Association of Rate-Controlled Persistent Atrial Fibrillation With Clinical Outcome and Ventricular Remodelling in Recipients of Cardiac Resynchronization Therapy

Canadian Journal of Cardiology

Volumn 27, Issue 6, 2011, Pages 787-793

  Wilton, Stephen B ^a   Kavanagh, Katherine M ^a   Aggarwal, Sandeep G ^a   Philippon, François ^b   Yee, Raymond ^c   Cowan, Karen ^a   Exner, Derek V ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART LEFT VENTRICLE CONTRACTION; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HUMAN; MALE; QUALITY OF LIFE; RECIPIENT; SINUS RHYTHM; SURVIVAL; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 82155185164     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.06.004     Document Type: Article

References (33)

1. Wells G., Parkash R., Healey J.S., et al. Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials. CMAJ 2011, 183:421-429.
2. Dickstein K., Bogale N., Priori S., et al. The European cardiac resynchronization therapy survey. Eur Heart J 2009, 30:2450-2460.
3. Wang T.J., Larson M.G., Levy D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003, 107:2920-2925.
4. Koplan B.A., Kaplan A.J., Weiner S., Jones P.W., Seth M., Christman S.A. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?. J Am Coll Cardiol 2009, 53:355-360.
5. Kamath G.S., Cotiga D., Koneru J.N., et al. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. J Am Coll Cardiol 2009, 53:1050-1055.
6. Tang A.S.L., Wells G.A., Talajic M., et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010, 363:2385-2395.
7. Molhoek S.G., Bax J.J., Bleeker G.B., et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 2004, 94:1506-1509.
8. Delnoy P.P., Ottervanger J.P., Luttikhuis H.O., et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 2007, 99:1252-1257.
9. Gasparini M., Auricchio A., Metra M., et al. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 2008, 29:1644-1652.
10. Khadjooi K., Foley P.W., Chalil S., et al. Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart 2008, 94:879-883.
11. Dickstein K., Vardas P.E., Auricchio A., et al. 2010 focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Eur Heart J 2010, 31:2677-2687.
12. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008, 117:e350-e408.
13. Howlett J.G., McKelvie R.S., Arnold J.M., et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 2009, 25:85-105.
14. Yu C.-M., Fung J.W.-H., Zhang Q., et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation 2004, 110:66-73. [see comment].
15. Surawicz B., Childers R., Deal B.J., Gettes L.S. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram, part III: intraventricular conduction disturbances. J Am Coll Cardiol 2009, 53:976-981.
16. Goldman L., Hashimoto B., Cook E.F., Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 1981, 64:1227-1234.
17. Berry C., McMurray J. A review of quality-of-life evaluations in patients with congestive heart failure. Pharmacoeconomics 1999, 16:247-271.
18. Bacharach S.L., Green M.V., Bonow R.O., Findley S.L., Ostrow H.G., Johnston G.S. Measurement of ventricular function by ECG gating during atrial fibrillation. J Nucl Med 1981, 22:226-231.
19. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346:1845-1853.
20. Bland J.M., Altman D.G. Statistics notes: the use of transformation when comparing two means. BMJ 1996, 312:1153.
21. Cleland J., Freemantle N., Ghio S., et al. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response: a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. J Am Coll Cardiol 2008, 52:438-445.
22. Gasparini M., Auricchio A., Regoli F., et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006, 48:734-743.
23. Delnoy P.P., Ottervanger J.P., Luttikhuis H.O., et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 2007, 99:1252-1257.
24. Lee T.H., Shammash J.B., Ribeiro J.P., Hartley L.H., Sherwood J., Goldman L. Estimation of maximum oxygen uptake from clinical data: performance of the Specific Activity Scale. Am Heart J 1988, 115:203-204.
25. Bennett J.A., Riegel B., Bittner V., Nichols J. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung 2002, 31:262-270.
26. Ypenburg C., van Bommel R.J., Borleffs C.J.W., et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009, 53:483-490.
27. Fornwalt B.K., Sprague W.W., BeDell P., et al. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 2010, 121:1985-1991.
28. Achilli A., Peraldo C., Sassara M., et al. Prediction of response to cardiac resynchronization therapy: the Selection of Candidates for CRT (SCART) study. Pacing Clin Electrophysiol 2006, 29:S11-S19.
29. Garcia-Seara J., Martinez-Sande J.L., Cid B., et al. Influence of the preimplantation QRS axis on responses to cardiac resynchronization therapy. Rev Esp Cardiol 2008, 61:1245-1252. [see comment].
30. Etienne Y., Mansourati J., Gilard M., et al. Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation. Am J Cardiol 1999, 83:1138-1140.
31. Leclercq C., Victor F., Alonso C., et al. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol 2000, 85:1154-1156.
32. Leon A.R., Greenberg J.M., Kanuru N., et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002, 39:1258-1263.
33. Wilton S.B., Leung A.A., Ghali W.A., Faris P., Exner D.V. Outcomes of cardiac resynchronization therapy in patients with versus without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 2011, 8:1088-1094.